hg_108751.1

Basic information about the TSS

---

TSS ID: hg_108751.1 Species: human Chr: chr10		Start: 27154365 End: 27154391 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000376016.8 ENST00000396296.7 BC024032 AK297973 Distance: 0 GeneID: 10730 HGNC/MGI_ID: HGNC:12843 UniProt_ID: Q5T8D2 Q96TA2

Gene_name: YME1 like 1 ATPase Gene_symbol: YME1L1 Gene_synonyms: YME1L Gene_source: HGNC:12843

TATA-Box annotation

---

Distance to TSS:	6
Nearest PromoterID:	NM_014263
Entrez ID:	10730
Nearest Unigene:	Hs.74647
Nearest Refseq:	NM_014263
Nearest Ensembl:	ENSG00000136758
Gene Name:	YME1 like 1 ATPase
Gene Alias:	FTSH|MEG4|OPA11|PAMP|YME1L
Gene Description:	YME1 like 1 ATPase
Gene Type:	protein-coding
CpG%:	0.075
GC%:	0.597015
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@YME1L1 p2@YME1L1 p3@YME1L1 p4@YME1L1 p5@YME1L1 p9@YME1L1
Sample		p1@YME1L1	p2@YME1L1	p3@YME1L1	p4@YME1L1	p5@YME1L1	p9@YME1L1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	49.87	7.01	6.04	5.65	4.68	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	49.57	6.88	5.26	5.46	2.63	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	48.03	7.72	6.56	6.17	5.40	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	34.72	3.95	4.57	5.41	3.12	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	46.12	5.40	6.30	7.42	2.25	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	44.96	7.17	4.07	7.17	3.29	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	55.78	11.11	5.01	3.70	1.96	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	56.92	6.78	3.63	3.88	3.15	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	54.93	9.62	2.35	1.50	2.56	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	49.85	11.01	12.17	2.90	5.22	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	63.87	6.06	10.11	3.64	3.23	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	53.26	14.23	6.50	1.63	3.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	29.50	11.28	0.32	0.00	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	31.27	12.03	0.30	0.30	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	33.59	12.29	0.22	0.22	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	25.65	9.31	1.51	0.75	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	27.96	5.24	0.22	0.22	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	32.48	5.91	0.00	1.27	1.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	26.12	3.20	2.13	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	29.19	10.83	1.05	0.90	1.20	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	31.94	9.09	1.60	1.34	0.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	32.11	11.22	0.69	0.52	0.69	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	28.82	10.47	1.03	0.65	0.39	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	23.78	8.74	0.73	0.24	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	26.57	14.71	0.77	1.03	1.55	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	28.49	7.60	0.63	0.00	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	24.18	7.14	1.10	0.00	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	35.60	16.27	1.41	1.41	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	28.27	10.66	0.81	0.81	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	36.37	10.50	1.63	0.72	0.72	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	26.17	7.96	0.42	0.84	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	28.53	10.75	0.39	0.39	1.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	28.07	8.86	0.63	0.42	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	31.17	10.56	0.99	1.65	0.99	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	26.55	11.41	2.06	0.93	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	33.34	10.73	2.30	0.38	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	36.18	10.63	0.82	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	28.41	10.48	1.21	0.81	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	34.84	10.26	1.35	1.08	1.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	30.97	11.04	1.68	0.00	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	35.29	8.70	1.88	0.94	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	33.09	11.86	1.46	0.44	0.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	35.43	18.77	0.84	0.42	1.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	31.99	10.31	0.87	1.22	1.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	42.76	14.25	1.20	0.80	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	36.53	11.17	0.93	1.16	0.93	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	35.03	8.40	1.92	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	39.34	13.41	1.19	1.19	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	41.89	15.32	2.15	1.20	1.91	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	40.04	13.55	1.42	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	37.51	16.19	2.05	0.61	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	50.70	12.90	0.67	1.11	0.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	27.98	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	28.39	14.19	0.71	0.35	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	37.12	11.60	0.99	0.33	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	51.18	22.65	3.36	1.68	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	48.68	7.81	2.30	1.38	1.38	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	38.89	16.85	1.62	0.32	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	38.86	12.85	1.61	0.64	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	59.41	21.69	3.14	2.20	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.02	14.10	3.53	0.71	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	24.67	9.53	1.68	1.12	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	74.04	24.68	1.59	1.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	42.81	16.99	1.36	1.36	2.72	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	42.24	22.42	1.95	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	35.50	16.68	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	129.31	48.49	16.16	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	86.87	31.59	15.79	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	32.18	11.70	0.98	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	41.16	21.32	0.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	53.01	18.30	0.94	1.88	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	84.12	19.21	2.65	0.99	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	49.19	13.30	1.24	1.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	43.72	14.37	1.83	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	42.92	8.24	1.27	0.32	1.43	0.16
Adipocyte - breast, donor2	11327-117E4	36.90	10.11	2.09	0.48	1.12	0.00
Adipocyte - omental, donor1	11473-119C6	43.64	10.43	1.15	0.89	1.40	0.00
Adipocyte - omental, donor2	11474-119C7	49.33	7.47	0.75	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	38.85	4.69	0.33	0.33	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	33.81	5.74	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	2.20	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	31.61	1.81	0.00	0.45	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	22.76	2.78	0.52	0.00	1.91	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	46.35	16.82	0.78	0.00	0.78	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	38.35	10.04	0.00	0.26	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	43.77	11.15	0.56	0.56	0.84	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	52.32	12.34	1.76	2.94	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	47.94	12.71	1.13	0.40	1.85	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	46.48	9.04	0.97	0.65	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	30.92	5.33	0.53	2.67	1.60	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	30.60	10.02	0.00	0.56	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	40.76	11.23	1.66	0.42	2.50	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	38.93	7.03	0.75	0.00	1.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	35.02	6.22	1.96	0.65	2.95	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	26.79	7.31	0.61	0.30	0.91	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	13.26	0.66	0.66	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.23	0.72	0.00	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	16.73	1.62	0.54	0.00	0.54	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	10.89	1.85	0.41	0.41	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	34.33	8.12	0.57	0.23	0.69	0.11
Anulus Pulposus Cell, donor2	11463-119B5	35.27	5.63	0.73	0.00	1.22	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	28.75	7.64	0.45	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	36.03	9.99	1.74	0.87	2.17	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	4.28	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	31.39	9.57	0.90	0.30	1.20	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	29.09	10.12	3.79	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	25.74	6.60	0.66	0.00	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	32.81	8.77	0.65	0.32	1.62	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	32.52	9.71	2.91	0.00	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.00	3.56	1.19	1.19	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	31.64	8.29	0.38	0.38	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	33.38	6.53	0.00	1.45	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	22.57	3.76	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	32.12	4.61	1.65	0.33	0.66	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	25.93	4.09	0.00	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	35.74	6.33	0.75	0.30	0.45	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	20.36	9.11	1.61	1.61	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	35.71	5.67	0.94	0.00	1.51	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	25.12	4.28	0.27	1.60	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	23.41	3.90	1.95	0.00	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	30.19	5.14	1.00	0.33	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	21.61	2.40	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	49.56	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	30.19	5.83	0.69	0.34	1.37	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	25.24	7.28	0.97	0.49	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	31.11	8.73	1.14	0.38	2.28	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	18.17	4.85	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	30.78	7.41	0.57	1.14	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	27.58	8.34	1.07	0.00	0.86	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	22.20	6.71	0.26	0.26	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	30.50	4.69	0.47	0.00	1.88	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	30.87	7.40	0.96	0.96	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	19.26	3.57	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	24.57	6.43	1.17	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	25.29	6.92	0.90	0.30	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	17.82	4.75	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	28.48	4.07	1.53	3.05	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	29.29	8.66	1.78	1.02	1.53	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	18.43	5.08	1.27	0.00	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	25.89	4.75	3.45	0.43	1.73	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	28.79	8.04	0.85	0.21	1.06	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.98	6.09	1.16	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	31.18	4.72	0.94	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	29.33	8.14	0.68	1.02	1.19	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	11.58	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	2.11	2.11	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	35.38	7.08	1.07	0.64	1.50	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	24.67	4.21	2.41	1.20	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	31.35	8.02	1.46	1.46	1.46	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	31.26	6.44	0.69	0.46	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	37.12	4.83	1.53	0.76	2.29	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	33.86	8.46	0.21	0.83	0.41	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	26.62	7.04	0.92	1.53	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	33.94	10.04	2.39	0.96	2.39	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	34.15	6.87	1.55	0.67	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	22.89	6.10	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	24.92	6.09	0.55	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	33.89	7.68	1.32	0.26	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	25.44	7.27	1.09	0.36	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	15.11	3.07	0.12	0.00	0.37	0.00
Astrocyte - cerebellum, donor2	11580-120F5	12.67	2.05	0.34	0.00	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	5.45	1.68	0.21	0.00	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	39.04	8.02	0.00	0.35	2.44	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	48.21	12.78	0.81	0.97	0.97	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	55.19	15.07	1.04	0.75	1.19	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	75.46	11.35	7.68	2.52	3.21	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	70.03	13.66	5.51	4.13	1.50	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	70.33	11.72	4.55	3.53	2.62	0.11
Basophils, donor1	12241-129G9	37.40	4.45	14.65	12.82	1.83	1.57
Basophils, donor2	12242-129H1	93.09	19.48	9.38	10.46	2.53	0.36
Basophils, donor3	12243-129H2	55.71	9.11	10.00	6.91	0.73	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	10.13	0.00	0.22	0.00	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.74	0.91	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	93.26	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	26.36	5.02	1.26	0.00	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	14.97	2.29	0.21	0.00	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	31.55	2.99	0.69	0.46	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	43.55	8.46	0.54	0.36	1.26	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	48.75	13.09	0.72	1.03	1.44	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	74.53	15.84	2.56	0.47	3.96	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	52.12	14.71	14.39	10.87	3.84	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	50.16	7.33	11.83	6.76	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	54.57	5.75	13.73	9.65	1.48	1.11
CD14+ Monocytes, donor3	11381-118B4	63.23	8.34	16.90	11.42	0.88	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	49.25	12.45	0.57	0.00	1.13	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	59.14	10.99	0.76	1.14	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	60.82	14.46	0.33	0.00	0.99	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	42.06	9.40	4.77	3.61	2.75	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	45.56	6.03	4.22	4.83	3.32	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	67.51	8.29	5.21	5.69	0.71	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	37.83	8.20	8.70	7.03	1.67	1.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	42.78	8.83	6.90	7.73	1.66	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	48.84	5.21	14.63	9.42	1.98	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	41.12	9.40	9.59	9.01	0.78	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	41.49	7.66	10.33	7.12	3.03	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	45.92	9.58	13.93	13.93	1.74	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	35.59	5.15	14.28	10.54	1.40	1.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	43.30	8.45	14.78	9.50	1.58	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	37.72	3.33	24.41	12.20	2.22	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	37.19	6.40	7.73	5.80	0.59	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	45.10	6.39	3.99	4.79	2.79	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	47.05	9.99	8.74	11.24	2.71	1.67
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	42.78	10.30	19.22	18.53	1.37	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	40.72	6.56	10.41	9.05	0.90	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	46.26	6.98	15.71	20.51	3.06	4.36
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	39.27	7.80	5.11	3.50	1.88	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	43.62	9.07	6.11	5.06	2.79	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	61.02	4.63	4.63	8.84	1.68	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	42.99	6.80	16.35	11.39	1.65	1.84
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	57.42	7.40	11.62	9.16	1.41	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	68.44	10.53	12.72	20.62	1.75	2.63
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	33.48	7.32	9.42	5.93	2.27	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	49.43	4.83	6.32	7.06	1.86	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	51.30	7.98	10.99	13.80	2.59	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	37.67	8.19	15.97	11.88	0.41	2.05
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	42.65	7.19	12.52	7.19	1.16	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	41.53	6.03	16.94	22.27	0.93	2.55
CD14+CD16+ Monocytes, donor1	11789-124B7	37.93	4.58	2.83	6.10	1.09	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	45.74	6.93	10.63	8.08	0.92	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	40.72	4.33	3.47	7.36	1.08	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	47.81	8.72	4.67	4.20	1.71	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	44.71	6.11	4.72	2.45	1.40	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	63.55	7.80	4.68	3.12	0.45	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	39.55	3.83	5.36	6.12	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	45.45	4.61	5.49	4.61	1.10	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	53.27	5.05	4.00	4.63	0.84	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	54.87	12.19	2.03	4.06	2.03	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	60.34	10.85	4.75	2.71	2.03	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	55.92	8.28	6.21	3.11	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	61.30	7.46	15.99	10.66	2.67	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	68.08	12.33	2.14	2.68	3.75	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	56.86	11.23	6.32	5.62	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	58.83	10.20	6.27	2.35	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	65.91	11.86	6.59	5.27	2.64	2.64
CD19+ B Cells, donor1	11544-120B5	111.78	10.68	15.62	14.79	2.47	1.64
CD19+ B Cells, donor2	11624-122B4	83.42	13.78	14.51	5.08	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	108.03	12.12	18.17	11.11	2.02	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	104.65	10.10	0.81	0.00	1.21	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	79.10	9.19	0.40	0.80	1.20	0.40
CD34+ Progenitors, donor1	11545-120B6	35.14	9.04	8.03	7.03	3.01	0.00
CD34+ Progenitors, donor2	11625-122B5	77.53	17.98	12.36	6.18	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	67.26	14.65	4.51	2.25	1.13	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	52.09	12.63	2.93	4.28	2.25	0.68
CD4+ T Cells, donor1	11225-116C1	172.82	20.35	14.64	14.28	1.07	2.14
CD4+ T Cells, donor2	11306-117C1	112.67	15.92	17.76	25.72	0.00	5.51
CD4+ T Cells, donor3	11382-118B5	131.45	13.42	17.99	17.38	0.91	1.52
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	74.78	8.68	4.08	3.83	1.79	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	82.65	7.86	2.47	3.37	2.25	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	78.76	11.21	2.87	2.59	2.30	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	102.40	15.65	9.48	11.85	0.95	4.27
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	113.78	13.34	9.83	12.64	1.40	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	164.81	6.59	6.59	23.07	3.30	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	70.96	11.42	3.76	4.62	1.30	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	63.38	9.66	2.20	1.69	1.36	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	60.94	10.16	3.87	5.80	0.81	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	90.56	8.97	7.17	10.31	2.24	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	81.06	9.78	6.29	14.32	1.40	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	91.52	5.72	10.12	11.44	1.76	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	59.03	7.59	1.69	0.00	1.26	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	63.37	9.56	1.45	1.45	0.83	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	48.78	8.35	2.67	0.33	1.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	82.40	12.78	9.52	11.69	2.72	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	140.42	14.47	6.97	8.58	1.07	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	98.63	7.17	12.55	5.38	5.38	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	74.91	9.09	2.60	1.48	2.04	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	73.22	11.05	1.08	0.87	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	71.24	9.46	1.68	2.73	1.68	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	82.92	11.12	11.12	15.17	2.02	2.53
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	84.92	8.23	15.16	12.56	2.60	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	120.72	12.20	9.15	15.69	1.31	2.61
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	88.09	13.36	1.98	3.96	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	83.09	12.92	1.85	0.92	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	67.00	9.77	2.79	5.58	4.19	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	108.83	14.68	5.54	2.77	1.94	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	127.85	15.71	1.23	1.47	0.98	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	84.70	9.24	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	92.39	16.83	0.72	1.43	1.43	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	85.87	13.85	1.38	6.92	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	131.94	17.35	15.06	18.01	1.31	2.29
CD8+ T Cells, donor2	11307-117C2	122.02	18.02	18.77	21.40	0.00	1.50
CD8+ T Cells, donor3	11383-118B6	138.36	19.69	18.94	21.97	1.26	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	58.95	7.34	0.23	1.38	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	47.93	3.35	0.48	0.72	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	41.86	7.39	0.82	0.55	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	69.65	7.81	1.20	1.50	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	60.48	5.52	0.24	0.96	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	52.53	7.96	0.45	1.14	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	58.88	5.87	0.43	0.43	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	53.69	3.68	0.53	1.58	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	64.49	7.50	0.94	0.47	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	66.41	7.25	0.60	1.81	0.00	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	52.87	9.59	0.87	1.16	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	73.27	6.66	0.27	1.07	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	77.48	7.00	3.06	2.19	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	81.07	6.83	1.82	4.10	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	61.91	2.98	2.24	4.48	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	51.50	6.12	0.72	1.44	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	53.80	6.04	1.73	0.00	0.58	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	41.72	4.48	0.24	0.94	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	72.25	3.80	0.32	1.90	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	70.43	6.46	0.31	0.92	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	69.25	4.49	0.32	1.92	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	68.08	4.21	0.38	1.53	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	77.24	5.12	0.39	1.58	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	68.83	6.81	1.51	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	95.55	8.83	7.23	3.21	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	104.91	13.29	4.90	8.39	1.40	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	97.17	9.02	4.01	8.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	49.35	5.48	0.00	1.83	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	29.65	5.93	0.49	0.00	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	45.99	14.31	0.84	0.74	1.05	0.11
Chondrocyte - de diff, donor1	11261-116G1	67.60	12.83	1.73	0.00	1.04	0.00
Chondrocyte - de diff, donor2	11338-117F6	29.14	2.13	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	33.11	7.28	0.80	0.11	1.71	0.00
Chondrocyte - re diff, donor2	11339-117F7	65.35	11.64	0.00	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	37.61	9.71	1.21	0.81	1.21	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	46.13	11.36	0.92	0.23	1.49	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	36.13	12.40	0.86	0.43	1.71	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	40.71	12.92	0.71	0.35	1.50	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	34.30	5.32	0.83	0.55	2.02	0.00
Corneal Epithelial Cells, donor1	11526-119I5	6.15	0.66	0.00	0.00	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	5.69	2.28	0.00	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	16.62	1.53	0.26	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	50.19	9.74	0.50	0.66	0.50	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	48.57	12.93	0.32	1.26	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	13.80	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	39.09	10.47	0.76	0.97	0.11	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	98.05	15.72	6.83	2.73	0.00	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	102.50	25.46	9.14	5.22	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	133.57	24.68	5.32	1.94	1.45	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	21.35	5.34	0.67	0.00	0.83	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	17.02	8.21	0.00	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	21.49	1.98	0.00	0.00	1.70	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	22.41	2.36	0.00	0.39	0.79	0.39
Endothelial Cells - Artery, donor1	11264-116G4	27.05	7.85	1.16	0.58	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	40.23	11.06	0.47	0.24	1.18	0.00
Endothelial Cells - Artery, donor3	11413-118E9	24.37	5.08	0.70	0.00	0.88	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	33.47	9.97	0.89	0.44	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	41.08	10.95	1.22	0.30	1.52	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	43.98	7.61	0.00	0.85	1.13	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	18.72	5.94	2.67	0.59	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	23.43	4.17	1.04	0.00	1.56	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	13.33	4.68	0.43	0.14	0.43	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	48.41	12.00	0.80	0.00	1.60	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	20.96	8.39	1.05	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	51.44	16.65	0.50	0.25	1.37	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	43.02	12.17	0.65	0.00	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	47.26	11.48	0.49	0.00	0.49	0.00
Endothelial Cells - Vein, donor1	11267-116G7	28.44	9.10	0.00	0.00	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	10.48	2.10	0.00	0.00	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	34.70	7.07	0.31	0.00	0.63	0.00
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	146.87	9.90	47.86	61.06	6.60	1.65
Eosinophils, donor3	12246-129H5	85.60	3.57	32.10	28.53	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	8.31	1.47	0.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	43.51	10.67	0.41	1.23	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	23.54	5.15	0.66	0.22	0.44	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	27.73	5.42	0.54	0.22	1.08	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	40.87	12.25	0.73	0.24	1.21	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	66.33	12.83	1.77	0.41	0.55	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	35.33	7.49	0.74	0.53	1.16	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	86.16	9.49	0.79	0.79	1.05	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	49.83	10.30	0.33	0.00	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	36.29	10.43	0.91	0.91	1.36	0.00
Fibroblast - Cardiac, donor2	11345-117G4	29.56	6.06	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	21.92	8.20	0.79	0.47	0.95	0.00
Fibroblast - Cardiac, donor4	11452-119A3	53.65	16.67	0.30	0.00	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	53.81	14.34	0.76	0.38	1.27	0.00
Fibroblast - Cardiac, donor6	11460-119B2	45.02	11.37	0.61	0.15	1.06	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	21.30	3.48	0.27	0.00	0.94	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	40.99	13.81	1.73	0.00	1.29	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	65.92	17.58	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	27.22	1.85	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	37.99	10.35	0.34	0.00	2.20	0.00
Fibroblast - Dermal, donor1	11269-116G9	50.95	7.51	0.23	0.23	1.41	0.00
Fibroblast - Dermal, donor2	11346-117G5	24.53	2.83	0.00	0.00	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	36.39	5.08	0.73	0.12	0.85	0.00
Fibroblast - Dermal, donor4	11450-119A1	62.51	8.48	0.79	0.23	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	60.19	7.85	0.17	0.35	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	64.48	8.61	0.32	0.00	0.97	0.00
Fibroblast - Gingival, donor1	11237-116D4	52.89	10.20	0.62	0.21	0.83	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	53.97	9.96	1.05	0.52	1.05	0.00
Fibroblast - Gingival, donor2	11318-117D4	49.81	8.57	0.53	0.13	0.66	0.00
Fibroblast - Gingival, donor3	11394-118C8	49.21	8.99	1.16	0.19	1.06	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	39.48	14.54	1.04	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	36.47	10.57	1.06	0.18	1.41	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	58.62	12.16	0.47	0.16	1.09	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	46.52	9.06	0.41	0.27	0.41	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	16.59	3.53	1.41	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	52.06	13.31	0.44	0.15	0.73	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	51.54	9.54	0.55	0.27	0.55	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	73.71	15.69	0.33	0.00	0.99	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	48.86	16.73	1.03	0.59	1.61	0.00
Fibroblast - Lung, donor1	11270-116H1	19.03	1.36	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	41.78	14.92	0.00	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	38.83	7.39	0.42	0.42	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	14.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	16.78	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.64	0.00	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	21.11	3.25	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	58.77	9.70	0.39	0.00	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	64.01	10.62	0.30	0.30	1.06	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	78.64	8.87	0.00	0.00	0.92	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	90.06	14.50	0.76	0.00	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	38.07	9.99	0.27	0.27	0.81	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	46.62	10.67	0.70	0.35	0.23	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	43.88	12.82	0.22	0.11	0.55	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	20.12	1.02	0.41	0.00	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	2.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	30.84	9.49	0.40	0.00	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	108.75	12.70	1.98	0.60	0.99	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	44.94	4.97	1.60	0.18	1.60	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	57.94	10.05	1.18	1.38	0.99	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	106.20	14.14	1.50	0.30	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	55.38	13.39	1.19	0.43	0.86	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	84.53	11.64	0.76	0.25	1.01	0.00
Fibroblast - skin normal, donor1	11553-120C5	48.73	4.43	0.98	0.33	0.98	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	104.66	14.84	0.80	0.20	2.21	0.00
Fibroblast - skin normal, donor2	11561-120D4	65.60	11.35	0.80	0.20	1.11	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	117.27	19.04	0.60	0.00	1.21	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	41.92	8.45	0.66	0.17	1.33	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	51.63	11.97	1.03	0.00	1.03	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	113.31	16.09	2.63	0.33	0.99	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	59.44	13.63	1.17	0.11	0.75	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	46.89	5.57	0.51	0.17	0.67	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	33.09	8.00	1.25	0.00	1.57	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	155.12	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	69.72	15.69	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	39.53	6.93	1.21	1.21	1.91	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	49.45	8.07	1.82	0.52	1.04	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	50.59	11.24	0.51	0.00	1.02	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	29.09	5.36	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	38.28	6.38	1.28	0.00	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	57.05	18.54	0.57	0.57	1.71	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	59.01	13.24	0.00	0.28	1.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	45.21	11.87	0.91	0.46	2.05	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	51.71	17.04	0.59	0.59	1.19	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	51.55	11.90	0.00	0.53	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	52.51	14.68	0.65	0.33	1.63	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	39.36	12.38	2.21	0.00	1.33	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	51.44	11.73	0.99	0.42	1.41	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	53.69	13.18	0.99	0.37	1.48	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	39.76	12.09	1.34	0.27	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	53.27	13.13	1.61	0.87	0.99	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	43.05	12.87	1.38	0.28	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	35.98	11.18	0.41	1.22	1.22	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	45.64	11.18	0.46	0.46	1.37	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	39.74	7.85	0.87	0.25	1.25	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	59.23	10.71	0.66	0.66	1.09	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	38.12	13.59	2.07	0.89	1.48	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	41.96	10.81	0.48	0.79	2.86	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	51.61	13.18	0.22	0.00	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	44.56	8.47	0.60	0.20	2.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	48.35	13.40	0.85	0.51	1.19	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	38.31	8.69	0.89	0.89	2.48	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	47.14	8.95	1.04	0.73	2.91	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	50.72	7.51	0.68	0.34	2.39	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	43.82	10.40	0.89	0.11	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	43.26	9.73	1.00	0.67	2.91	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	47.17	7.55	1.63	0.61	2.25	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	45.18	10.73	1.65	0.00	2.48	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	52.23	12.34	1.38	0.35	1.96	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	45.36	11.17	0.50	0.50	3.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	41.66	8.60	0.22	0.22	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	48.46	12.79	0.61	0.37	2.34	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	44.74	10.70	1.62	0.32	2.92	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	54.52	6.09	0.96	0.00	2.57	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	40.55	10.99	0.47	0.28	2.18	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	32.74	7.12	0.32	0.16	0.63	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	37.40	11.25	0.91	0.61	1.82	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	45.37	8.78	0.84	0.21	2.82	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	40.62	8.34	0.22	0.22	2.63	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	39.00	8.14	1.40	0.56	2.81	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	43.15	11.85	0.56	0.46	3.33	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	28.88	8.82	0.80	0.27	1.87	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	49.27	10.71	1.07	0.77	2.60	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	39.38	10.88	1.55	0.39	1.04	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	39.03	11.93	0.81	0.27	1.36	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	34.84	12.54	0.74	0.18	2.40	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	37.94	13.82	0.88	0.88	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	47.60	10.91	0.00	0.00	2.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	41.55	10.82	1.19	0.53	2.51	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	40.15	12.11	0.20	0.20	1.82	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	42.95	10.17	0.76	0.00	3.05	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	58.32	18.71	0.60	0.20	1.99	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	50.85	11.71	0.31	0.46	1.23	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	58.72	18.00	0.82	0.41	2.05	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	33.80	11.27	0.31	0.31	0.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	29.39	9.04	0.00	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	47.50	14.30	0.00	0.00	2.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	49.50	19.80	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	47.58	19.73	1.16	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	67.39	9.63	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	38.25	10.43	0.00	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	43.61	13.34	0.65	0.00	1.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	42.42	17.30	0.00	0.00	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	59.98	10.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	40.27	13.14	0.00	0.00	1.12	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	34.32	14.38	0.00	0.65	1.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	24.33	7.55	1.68	0.00	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	42.62	15.90	0.00	0.32	1.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	31.59	12.57	0.68	0.34	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	52.20	2.09	0.00	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	45.82	9.16	0.00	0.00	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	25.75	9.18	0.00	0.00	0.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	33.88	16.94	1.69	1.69	5.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	39.35	15.74	0.41	0.00	2.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	50.63	11.74	0.92	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	15.81	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	40.75	15.38	0.00	0.38	1.54	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	36.51	14.34	0.33	0.00	1.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	46.15	19.40	0.00	0.00	3.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	50.47	13.87	0.39	0.39	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	65.39	19.17	1.37	0.34	2.05	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	72.06	7.45	7.45	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	54.26	11.80	0.94	0.00	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	47.07	13.88	0.00	0.60	1.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	49.34	13.73	0.00	0.00	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	52.65	17.15	0.80	1.60	2.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	57.72	11.84	0.00	0.49	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	74.37	27.15	7.08	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	57.76	15.75	0.00	0.00	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	62.76	10.97	1.76	0.00	3.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	55.10	13.56	0.00	2.54	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	30.44	13.13	0.00	0.60	2.39	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	33.00	15.53	0.97	0.49	1.94	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	46.79	6.85	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	30.35	7.07	0.00	0.00	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	13.49	3.37	0.00	0.00	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	30.76	4.44	2.22	0.63	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	33.42	3.76	0.42	0.84	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	42.36	6.27	0.58	0.35	0.70	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	47.10	6.08	0.51	0.00	0.68	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	44.36	4.78	0.46	0.46	1.37	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	38.48	6.45	0.33	0.55	0.77	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	44.27	3.87	0.00	0.21	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	47.15	4.95	0.22	0.22	1.51	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	42.72	7.72	0.87	0.62	0.62	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	40.66	5.49	0.69	0.51	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	44.85	6.09	0.32	0.96	1.28	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	11.19	1.12	1.12	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.03	0.43	0.87	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	47.59	10.58	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	11.99	0.71	0.00	0.00	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.27	1.45	0.00	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	41.79	14.51	0.17	0.00	0.52	0.00
Hepatocyte, donor1	11523-119I2	85.95	12.11	0.00	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	57.10	14.01	0.00	0.00	3.23	0.00
Hepatocyte, donor3	11684-122I1	79.76	14.11	1.23	1.84	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	67.23	7.83	2.61	1.96	2.61	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	59.78	16.95	0.70	1.05	1.75	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	38.14	12.62	0.41	0.00	1.78	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	57.31	0.00	0.00	3.18	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	6.68	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	34.61	1.38	0.00	2.77	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	35.04	0.00	10.01	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	0.00	0.00	0.00	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	53.82	2.56	10.25	2.56	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	55.23	4.87	0.00	1.62	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	26.68	6.67	1.67	5.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	29.12	2.65	1.32	3.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	45.45	3.33	0.00	3.33	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	78.57	0.00	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	32.12	2.52	1.26	1.89	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	47.95	1.55	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	36.82	3.23	3.23	1.29	1.94	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	37.03	3.22	1.61	8.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	28.52	5.70	1.63	1.63	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	16.79	1.68	0.42	2.52	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	42.60	2.41	1.61	1.61	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	28.62	2.77	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	0.00	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	28.79	1.89	1.42	0.00	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	31.74	2.72	0.91	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	34.44	0.00	0.00	1.08	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	38.11	3.81	1.27	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	24.87	3.19	0.00	0.64	3.83	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	32.81	1.82	0.00	1.82	3.65	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	30.70	3.57	1.43	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	0.00	3.32	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	31.48	2.47	0.62	0.00	1.54	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	24.58	0.00	1.76	0.00	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	44.00	3.14	3.14	0.00	9.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	39.64	3.48	2.09	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	46.47	2.21	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	3.24	6.48	6.48	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	21.80	2.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	36.00	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	26.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	37.41	4.16	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	62.69	2.85	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	28.53	0.92	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	55.88	0.00	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	16.92	2.11	0.00	1.06	5.29	0.00
Keratinocyte - epidermal, donor1	11272-116H3	26.19	4.41	0.90	0.33	1.14	0.00
Keratinocyte - epidermal, donor2	11349-117G8	13.47	1.17	0.00	0.00	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	51.59	7.86	0.47	0.38	1.04	0.00
Keratinocyte - oral, donor1	11251-116E9	64.14	9.54	0.34	0.57	1.25	0.00
Keratocytes, donor1	11527-119I6	38.51	4.47	0.34	0.34	1.38	0.00
Keratocytes, donor2	11607-120I5	7.03	2.34	1.17	0.00	2.34	0.00
Keratocytes, donor3	11688-122I5	67.97	12.65	1.38	0.20	1.58	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	118.69	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	33.44	8.63	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	44.29	11.42	0.92	0.46	1.85	0.00
Lens Epithelial Cells, donor3	11690-122I7	55.00	15.54	1.31	0.40	1.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	22.89	9.72	1.42	0.83	0.95	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	9.49	3.35	1.95	0.28	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	27.70	12.59	2.20	0.31	0.94	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	15.59	2.69	2.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	6.62	3.15	1.26	0.63	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.52	4.10	0.75	0.22	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	25.44	3.69	0.41	1.23	1.23	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.54	2.53	0.51	0.25	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.96	3.80	1.55	0.28	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	23.73	7.12	2.37	0.00	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	17.84	5.82	1.55	0.39	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.18	2.41	0.74	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	16.72	5.92	0.35	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.50	3.82	0.72	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.75	3.43	1.24	0.27	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	19.40	7.39	1.85	0.92	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	9.04	1.25	0.00	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	7.69	3.66	1.65	0.18	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	20.40	6.58	1.97	0.00	1.32	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.03	2.93	0.88	0.88	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.98	4.23	1.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	21.34	3.88	0.97	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	17.23	6.46	1.08	0.27	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	12.87	6.51	0.91	0.61	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	13.48	5.70	0.00	1.04	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	23.45	7.75	1.26	1.05	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.32	5.56	0.60	0.15	0.60	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	16.51	7.57	1.38	1.38	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	14.86	5.08	0.38	0.38	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	6.04	2.65	1.06	0.32	0.85	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	23.26	4.36	0.97	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	14.55	4.63	0.99	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.29	3.10	0.37	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.62	10.37	1.85	0.37	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	17.30	3.95	0.49	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.42	3.16	0.55	0.27	0.41	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	26.70	4.18	1.29	0.00	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	23.13	4.87	2.74	0.61	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	18.48	7.42	0.84	0.28	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	20.98	7.11	1.42	0.36	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.73	1.94	0.97	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.98	2.65	0.31	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	19.34	5.01	0.00	0.72	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.43	2.61	1.31	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.12	1.65	0.47	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	25.74	9.41	1.11	0.25	0.50	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.68	2.31	0.26	0.26	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	13.13	4.48	0.90	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	4.53	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	30.69	7.67	1.53	0.00	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	24.49	2.97	2.23	1.48	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	19.04	6.35	1.27	2.12	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	22.51	5.63	2.11	2.81	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	18.68	10.27	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	19.06	2.58	1.55	1.03	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	24.98	4.76	2.38	4.76	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	18.77	4.30	0.90	0.90	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	32.86	4.36	1.16	0.58	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	39.62	7.20	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	19.92	4.06	1.49	1.63	1.76	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	20.03	2.57	2.05	1.54	2.05	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	37.76	6.00	2.12	1.06	1.76	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	30.65	3.33	1.33	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	23.94	5.09	2.04	2.04	2.04	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	42.96	9.61	1.87	0.53	1.60	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	32.31	9.45	2.46	0.94	2.08	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	23.32	1.23	1.23	1.23	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	39.96	8.97	0.82	1.63	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	38.11	9.79	1.25	0.83	0.83	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	36.71	3.36	1.68	2.52	1.68	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	40.18	8.24	2.06	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	39.48	9.00	2.03	1.16	2.61	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	28.10	5.68	0.90	0.60	1.20	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	40.94	12.17	1.11	0.55	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	26.51	8.13	2.12	1.41	2.83	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	25.45	4.06	0.74	1.48	1.48	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	2.30	2.30	2.30	3.45	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	22.64	8.06	2.69	1.15	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	24.91	1.70	0.57	0.57	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	29.54	1.64	1.64	0.00	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	24.40	5.87	3.62	0.90	3.62	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	28.73	2.87	2.87	0.72	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	42.57	8.22	0.00	1.49	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	20.44	6.32	2.23	0.74	1.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	21.11	3.88	1.29	0.86	1.29	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	26.55	9.42	0.00	0.86	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	24.66	11.99	2.00	1.00	1.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	33.79	3.02	2.41	1.81	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	25.60	6.40	2.13	0.00	2.84	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	28.87	6.87	2.41	1.72	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	24.15	2.15	2.68	0.54	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	25.59	4.71	1.35	1.35	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	22.59	8.89	3.33	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	18.61	9.30	1.16	1.16	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	27.50	8.46	0.00	1.06	3.17	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	23.61	6.00	2.40	0.80	1.60	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	22.53	2.91	2.91	0.73	2.91	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	28.36	9.96	1.53	4.60	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	31.57	5.43	3.45	1.97	0.99	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	14.11	6.59	1.88	3.76	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	21.62	9.55	1.51	3.02	2.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	27.04	6.76	1.80	0.90	1.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	0.00	1.72	0.00	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	25.83	7.13	2.23	3.12	1.78	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	26.59	5.08	3.13	3.13	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	15.83	5.28	3.30	1.98	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	24.39	3.11	4.15	2.08	3.11	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	31.50	7.44	0.44	3.94	3.06	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	27.96	2.24	1.12	1.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	30.47	6.62	1.32	1.77	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	27.00	6.17	0.77	1.54	1.16	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.23	3.54	1.52	1.01	2.03	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	27.88	5.29	2.40	1.44	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	26.64	6.36	1.99	2.39	1.19	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	17.62	2.43	2.43	1.22	2.43	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	23.52	2.08	1.38	1.38	2.77	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	20.52	11.02	1.14	2.28	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	19.62	3.10	0.52	0.00	2.58	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	22.37	6.05	1.21	0.60	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	25.67	6.97	0.95	0.95	1.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	21.32	2.13	2.13	0.53	1.60	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	16.09	1.72	0.57	0.00	2.87	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	19.54	4.11	1.54	2.57	4.63	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	24.05	4.24	2.12	1.41	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	24.40	2.84	1.13	1.70	3.97	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.14	3.74	2.08	2.91	1.66	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	11.75	2.35	2.35	0.78	1.57	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	29.23	5.01	0.84	2.09	1.67	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	18.12	5.11	1.86	1.86	1.39	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.73	0.67	2.68	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	28.34	5.35	4.81	1.07	1.60	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	26.67	4.45	3.64	2.02	1.62	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.03	6.42	1.84	0.92	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	22.23	2.67	2.67	0.00	2.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	27.92	7.41	1.71	1.71	4.56	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	19.94	4.60	3.07	2.30	3.83	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	38.30	6.57	1.64	0.55	2.19	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	24.05	7.13	2.67	0.89	1.78	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	20.28	6.76	1.56	0.78	2.08	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	23.21	6.63	3.98	0.66	1.99	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	31.18	8.31	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	34.87	9.80	0.23	0.00	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	50.10	9.54	0.55	1.28	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	50.07	8.00	1.05	0.39	0.52	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	35.58	3.19	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	46.58	6.34	1.27	0.63	1.74	0.00
Mallassez-derived cells, donor3	11930-125I4	42.53	6.39	1.39	0.28	1.11	0.00
Mammary Epithelial Cell, donor1	11273-116H4	70.15	13.35	1.30	0.50	0.80	0.00
Mammary Epithelial Cell, donor2	11350-117G9	57.33	7.24	0.29	0.87	1.16	0.00
Mammary Epithelial Cell, donor3	11422-118F9	13.47	4.99	0.50	0.50	1.25	0.00
Mast cell - stimulated, donor1	11487-119E2	85.42	37.96	0.68	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	76.78	10.81	0.87	0.43	0.43	0.11
Mast cell, donor2	11565-120D8	84.40	12.48	18.72	6.54	0.89	2.38
Mast cell, donor3	11566-120D9	96.35	10.58	12.16	11.93	1.35	1.13
Mast cell, donor4	11567-120E1	84.57	10.28	25.35	10.81	1.95	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	87.16	11.53	0.67	1.33	0.11	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	56.03	5.84	0.58	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	54.26	8.03	0.34	0.00	0.57	0.00
Mast cell, expanded, donor8	11941-126A6	46.70	10.71	0.50	1.00	1.00	0.17
Melanocyte - dark, donor1	11502-119F8	35.22	16.02	0.80	0.30	0.90	0.10
Melanocyte - dark, donor2	11582-120F7	35.30	6.58	0.00	0.00	2.42	0.00
Melanocyte - dark, donor3	11663-122F7	69.40	11.81	0.72	0.36	1.96	0.00
Melanocyte - light, donor1	11274-116H5	16.69	2.35	0.24	0.00	0.71	0.00
Melanocyte - light, donor2	11351-117H1	8.87	1.36	0.00	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	9.54	5.20	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	43.42	9.68	0.31	0.21	0.83	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	34.16	13.18	1.08	0.00	1.08	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	51.70	8.84	2.14	0.00	3.75	0.00
Meningeal Cells, donor1	11493-119E8	31.01	3.72	0.25	0.00	0.25	0.00
Meningeal Cells, donor2	11573-120E7	33.01	4.40	0.44	0.00	0.88	0.00
Meningeal Cells, donor3	11654-122E7	46.78	11.00	0.57	0.49	1.55	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	44.77	10.84	0.29	0.29	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	39.75	8.05	1.11	1.61	1.31	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	32.29	6.46	0.00	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	47.01	7.62	0.42	0.00	1.27	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	34.68	5.03	0.50	0.50	2.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	15.60	0.88	0.22	0.22	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	10.96	3.65	0.00	0.00	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	13.09	1.64	0.20	0.00	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	51.94	6.09	0.97	0.28	0.83	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	8.92	0.37	0.00	0.74	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	42.10	13.29	0.53	0.53	1.32	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	10.98	3.86	0.00	0.00	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	9.61	3.84	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	43.60	9.57	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	45.97	14.07	0.31	0.31	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	55.88	13.79	0.00	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	40.31	11.40	1.33	0.53	1.33	0.00
Mesothelial Cells, donor2	12156-128G5	25.52	8.51	0.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	42.56	9.61	1.16	0.72	0.94	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	31.06	10.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	57.63	13.79	0.25	0.49	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	51.53	11.19	1.18	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	44.94	6.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	43.70	14.26	0.93	1.24	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	39.00	7.88	1.45	1.87	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	37.06	2.32	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	42.29	9.76	2.50	2.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	45.62	10.24	1.40	1.40	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	41.25	8.74	2.64	1.22	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	43.56	7.92	1.19	1.58	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	17.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	29.20	7.08	0.00	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	36.47	8.36	2.66	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	40.79	13.16	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	31.41	8.70	2.97	4.46	0.21	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	30.39	3.68	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	39.05	7.75	1.19	2.09	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	46.95	6.71	5.03	0.00	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	35.63	9.79	2.01	2.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	35.65	8.08	1.43	0.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	47.00	10.50	0.55	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	43.75	7.60	1.38	3.91	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	49.22	8.83	3.16	2.94	0.21	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	48.51	7.75	2.45	1.83	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	46.34	5.79	1.72	1.07	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	43.35	8.00	2.00	2.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	61.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	39.42	8.10	1.75	0.88	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	45.12	7.10	1.52	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	54.68	16.57	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	53.27	10.60	1.90	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	50.88	10.29	1.47	2.06	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	35.98	13.08	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	42.29	10.57	0.96	2.40	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	49.63	10.81	1.20	2.80	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	80.90	24.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	51.56	10.51	2.00	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	134.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	95.81	16.31	2.04	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	77.07	16.64	2.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	112.57	20.97	1.10	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	92.86	28.82	0.64	1.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	76.36	15.37	0.99	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	67.50	17.40	0.70	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	185.63	30.94	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	64.27	12.99	1.37	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	91.90	21.01	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	85.22	16.33	2.13	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	53.59	12.34	0.84	1.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	115.13	25.35	1.25	1.25	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	98.48	24.48	0.58	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	57.01	9.35	0.30	1.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	106.02	24.21	1.67	2.92	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	79.41	14.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	61.88	12.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	100.73	21.06	2.85	2.28	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	77.11	17.13	3.18	0.97	0.55	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	56.75	9.33	0.78	2.07	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	111.53	25.74	3.43	0.86	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	85.12	15.88	1.27	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	60.32	13.88	0.27	1.07	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	87.40	13.17	2.39	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	54.10	13.00	0.99	0.85	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	42.68	12.42	0.64	0.00	0.96	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	117.64	21.23	1.99	1.11	0.00	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	81.91	12.13	0.76	1.14	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	64.78	13.64	1.70	1.42	0.28	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	88.74	16.47	3.93	1.47	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	85.37	12.38	0.65	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	54.98	12.94	1.18	1.18	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	72.37	13.55	3.75	1.73	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	45.75	3.71	1.24	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	57.17	8.34	0.30	0.30	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	7.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	7.13	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	29.90	10.19	0.33	1.64	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	32.61	7.36	3.16	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	38.15	6.13	0.99	0.99	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	48.43	7.45	0.93	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	31.92	7.89	0.38	0.00	1.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	36.22	6.66	0.53	0.27	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	28.61	5.43	0.57	0.23	0.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	19.89	1.47	0.74	0.74	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	25.28	9.89	0.73	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	34.22	7.78	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	25.65	8.55	2.67	1.60	1.07	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	16.16	7.07	1.01	2.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	35.00	5.48	0.84	1.26	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	39.50	5.45	5.45	12.26	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	17.80	2.54	8.27	3.81	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	32.39	6.48	12.15	9.72	3.24	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	33.23	3.02	9.06	4.53	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	17.13	97.07	45.68	0.00	17.13
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	55.46	9.79	32.62	39.15	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	4.75	9.50	9.50	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	25.10	12.55	25.10	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	54.51	4.09	1.51	0.43	1.08	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	38.15	6.27	0.52	0.00	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.02	11.35	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	29.22	15.44	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	76.06	27.57	0.38	0.38	1.14	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	89.37	31.92	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	13.60	8.16	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	71.67	12.86	0.00	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	16.74	7.12	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	56.48	16.50	0.00	0.23	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	18.92	7.03	0.00	0.00	0.81	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	44.99	13.24	1.05	0.21	1.05	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	18.86	7.45	0.00	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	39.52	14.62	0.81	0.00	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	27.66	8.39	0.23	0.45	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	30.70	10.94	0.16	0.00	0.49	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	40.46	11.12	0.55	0.36	0.73	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	25.46	4.77	0.00	0.00	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	11.41	7.20	1.20	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	57.76	12.47	1.31	0.00	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	19.84	8.46	0.16	0.16	0.49	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	37.39	11.82	1.41	0.35	0.71	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	21.10	7.74	0.70	0.00	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	31.26	11.03	0.46	0.00	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	26.03	9.32	0.96	0.00	1.29	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	56.56	21.04	2.07	1.38	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	83.44	17.70	0.00	2.53	10.11	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	39.43	12.03	0.22	0.00	0.89	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	38.95	19.90	0.42	0.42	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	51.27	17.80	0.24	0.47	1.42	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	19.32	9.01	0.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	117.36	45.14	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	28.99	10.33	0.00	0.00	1.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	30.21	14.43	0.00	0.45	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	20.24	9.13	0.40	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	6.50	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	56.00	21.95	0.38	0.00	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	18.90	10.75	0.33	0.00	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	23.97	10.46	0.44	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	36.18	15.38	1.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.99	9.70	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	15.96	9.31	1.33	0.66	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	21.33	8.93	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	21.06	10.34	0.38	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	52.32	23.29	0.30	0.30	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	36.03	10.83	0.66	0.66	1.33	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	23.72	10.16	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	76.64	15.33	5.11	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	19.51	9.75	0.61	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	40.92	17.63	0.63	0.00	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	29.05	14.53	0.30	0.30	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	14.24	8.70	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	71.42	21.54	0.00	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	91.04	5.06	0.00	0.00	10.12	0.00
Myoblast, donor1	11241-116D8	43.36	7.95	0.87	0.25	0.75	0.00
Myoblast, donor2	11322-117D8	43.73	9.01	1.34	0.00	1.92	0.00
Myoblast, donor3	11398-118D3	60.54	12.44	1.51	0.67	0.67	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	60.71	7.30	0.29	0.29	0.88	0.15
Natural Killer Cells, donor1	11230-116C6	118.70	17.53	20.30	23.99	0.62	3.08
Natural Killer Cells, donor2	11311-117C6	96.50	14.17	24.12	41.01	0.90	4.82
Natural Killer Cells, donor3	11387-118C1	110.25	16.38	25.95	34.05	0.55	3.13
Neural stem cells, donor1	11275-116H6	42.83	6.53	0.73	0.00	3.27	0.00
Neural stem cells, donor2	11352-117H2	51.99	9.63	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	47.79	13.65	1.14	0.00	2.28	0.00
Neurons, donor2	11574-120E8	36.11	6.60	0.22	0.22	0.88	0.00
Neurons, donor3	11655-122E8	40.29	5.76	0.82	0.00	2.47	0.00
Neutrophils, donor1	11233-116C9	112.29	13.92	7.42	7.42	0.93	0.93
Neutrophils, donor2	11314-117C9	104.36	8.70	5.80	5.80	0.00	0.00
Neutrophils, donor3	11390-118C4	183.25	20.16	20.16	12.83	2.44	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	45.00	12.94	0.47	0.83	1.42	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	23.44	5.86	0.00	0.00	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	43.32	8.62	0.40	0.20	1.60	0.00
Olfactory epithelial cells, donor1	11933-125I7	24.64	8.26	1.10	0.55	1.24	0.00
Olfactory epithelial cells, donor2	11934-125I8	35.03	12.01	1.30	0.72	0.87	0.14
Olfactory epithelial cells, donor3	11935-125I9	32.35	8.29	0.68	0.00	1.02	0.00
Olfactory epithelial cells, donor4	11936-126A1	51.23	11.98	0.68	0.19	1.17	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	55.97	18.05	1.20	1.20	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	27.22	1.91	1.28	0.00	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	9.14	2.29	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	22.97	3.72	0.00	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	7.43	2.15	0.00	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	67.42	9.13	0.00	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	41.23	9.06	0.89	0.36	1.42	0.00
Pancreatic stromal cells, donor1	11249-116E7	38.24	12.30	0.84	0.17	1.43	0.00
Pericytes, donor1	11491-119E6	5.01	0.56	0.33	0.00	0.45	0.00
Pericytes, donor2	11571-120E5	7.70	1.81	0.45	0.00	0.91	0.00
Pericytes, donor3	11652-122E5	17.50	2.64	0.00	0.20	0.61	0.00
Perineurial Cells, donor1	11499-119F5	61.03	11.98	0.79	0.11	1.36	0.00
Perineurial Cells, donor2	11579-120F4	47.39	14.54	0.46	0.46	1.47	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	92.75	4.78	3.19	3.19	0.64	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	65.62	9.06	12.00	15.18	1.71	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	76.48	8.54	5.95	2.85	0.91	0.26
Placental Epithelial Cells, donor1	11278-116H9	13.39	0.72	0.48	0.48	0.72	0.24
Placental Epithelial Cells, donor2	11355-117H5	19.96	2.22	0.00	0.00	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	12.56	4.32	0.20	0.20	0.59	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	31.33	7.28	0.63	0.00	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	34.33	4.31	0.75	0.56	1.50	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	84.19	16.84	0.78	0.65	0.91	0.00
Preadipocyte - breast, donor2	11328-117E5	38.05	8.33	0.68	0.00	1.80	0.00
Preadipocyte - omental, donor1	11468-119C1	37.93	7.78	0.85	0.64	1.70	0.00
Preadipocyte - omental, donor2	11329-117E6	51.50	7.86	0.44	0.44	2.62	0.00
Preadipocyte - omental, donor3	11403-118D8	60.45	9.74	0.86	0.43	0.86	0.14
Preadipocyte - perirenal, donor1	11469-119C2	18.70	0.98	0.00	0.00	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	15.66	3.38	0.61	0.31	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	56.84	11.16	0.71	0.18	0.53	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	44.61	9.88	1.02	0.85	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	53.09	9.97	0.37	0.19	0.84	0.00
Preadipocyte - visceral, donor2	11357-117H7	33.13	6.44	1.84	0.46	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	43.68	7.21	0.84	0.10	0.73	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	60.94	15.84	0.30	1.66	2.87	0.00
Prostate Epithelial Cells, donor2	11331-117E8	28.57	7.04	0.95	0.14	1.35	0.14
Prostate Epithelial Cells, donor3	11404-118D9	44.70	7.16	0.61	0.18	1.84	0.00
Prostate Stromal Cells, donor1	11254-116F3	44.65	9.45	0.68	0.68	0.80	0.00
Prostate Stromal Cells, donor2	11332-117E9	49.13	9.14	0.18	0.36	1.26	0.00
Prostate Stromal Cells, donor3	11405-118E1	32.33	8.65	0.94	0.52	1.46	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.41	1.09	0.36	0.00	1.09	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	32.30	6.10	0.83	0.21	1.11	0.00
Renal Epithelial Cells, donor1	11517-119H5	6.09	0.00	0.51	0.00	1.52	0.00
Renal Epithelial Cells, donor2	11597-120H4	4.27	2.85	2.13	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	37.58	7.52	1.38	0.74	1.27	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.21	0.68	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	18.19	3.37	0.81	0.00	0.94	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	65.94	13.99	0.22	0.22	1.78	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	4.66	2.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	11.22	1.32	0.22	0.66	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	7.52	3.76	1.25	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.22	0.28	0.00	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	25.23	3.49	0.00	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	15.60	2.11	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	13.31	2.12	0.00	0.00	0.58	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	42.00	7.26	0.52	0.26	1.30	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	14.78	3.13	0.28	0.00	1.14	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	1.03	0.00	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	14.55	1.76	1.00	0.25	2.26	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	55.33	10.16	0.80	0.67	1.47	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	35.74	5.36	0.89	1.79	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	41.83	4.40	2.20	2.75	2.75	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	37.12	3.48	0.00	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	52.27	9.75	1.17	0.00	1.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	30.69	6.36	1.19	0.40	2.09	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	43.50	8.14	0.78	0.67	2.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	65.62	13.27	1.74	0.37	1.61	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	34.85	5.94	1.75	0.00	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	40.22	5.32	0.69	0.00	1.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	59.28	8.90	2.19	0.27	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	39.03	7.41	0.61	0.45	1.66	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	45.34	8.60	0.36	0.72	3.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	56.38	7.03	1.15	0.29	1.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	33.70	8.26	1.18	0.86	1.40	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	36.29	7.08	1.33	0.89	1.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	72.46	7.26	0.96	0.76	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	30.09	6.24	0.93	0.65	1.86	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	42.28	4.70	0.94	0.38	2.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	57.73	8.23	1.46	0.27	1.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	46.24	8.47	0.68	0.49	1.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	38.38	8.21	2.67	0.38	2.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	66.53	7.90	1.28	0.53	1.50	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	42.61	6.45	1.96	1.12	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	38.11	7.35	1.03	0.51	4.10	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	75.48	10.03	1.28	0.36	1.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	34.83	6.62	0.61	0.86	1.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	44.59	7.39	1.61	0.81	1.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	69.58	6.60	2.36	0.24	1.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	31.55	5.56	0.99	0.40	2.78	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	36.25	6.55	2.10	0.47	3.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	59.93	7.46	2.07	0.00	1.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	25.88	4.87	1.55	1.55	3.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	38.02	5.85	1.04	0.63	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	53.83	9.82	1.88	0.00	2.42	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	52.11	8.86	1.53	1.70	2.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	38.94	9.64	1.74	0.77	1.74	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	71.70	8.94	1.03	0.34	1.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	44.58	7.41	0.82	0.55	2.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	38.74	8.54	0.49	0.82	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	63.91	8.52	1.02	0.17	1.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	36.84	6.51	1.18	0.15	1.63	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	46.11	5.33	1.33	0.00	2.93	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	43.00	6.78	1.38	0.14	2.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	32.14	5.48	1.19	0.00	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	45.95	6.85	0.81	1.01	1.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	45.02	6.87	0.57	0.66	1.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	30.74	7.69	1.75	1.05	1.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	36.87	7.25	0.91	1.21	2.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	48.59	5.14	1.10	0.12	1.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	68.56	9.75	1.75	1.31	3.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	29.81	6.08	1.22	0.00	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	59.68	6.93	1.51	0.60	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	30.99	8.14	1.58	0.90	2.26	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	49.12	11.38	1.50	0.60	1.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	37.08	7.20	0.12	0.24	1.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	27.96	6.19	0.85	0.43	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	52.89	13.82	1.80	0.60	0.60	0.00
Schwann Cells, donor1	11498-119F4	9.59	1.88	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	27.22	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	49.95	8.54	0.00	0.00	0.44	0.00
Sebocyte, donor1	11220-116B5	23.01	4.38	0.55	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	20.68	6.43	0.92	0.00	0.46	0.00
Sebocyte, donor3	11378-118B1	14.84	1.65	0.41	0.41	0.21	0.00
Sertoli Cells, donor1	11255-116F4	49.70	4.97	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	42.37	0.00	2.82	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	31.06	7.65	1.06	0.26	1.50	0.00
Skeletal Muscle Cells, donor2	11358-117H8	5.78	3.61	0.72	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	24.25	3.34	0.00	0.00	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	52.94	9.11	0.47	0.16	0.63	0.00
Skeletal Muscle Cells, donor5	11455-119A6	48.16	7.73	0.45	0.00	0.30	0.00
Skeletal Muscle Cells, donor6	11459-119B1	64.95	9.54	0.31	0.00	0.31	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	49.90	11.09	0.38	0.50	0.63	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	42.52	8.13	0.14	0.00	0.71	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	55.36	12.60	1.29	0.40	1.19	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	32.02	9.69	1.35	0.42	1.85	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	19.54	7.24	0.00	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	18.58	1.93	0.41	0.41	0.55	0.00
Skin - palm, donor1	10286-104F7	145.05	8.06	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	28.11	5.62	1.01	0.43	0.58	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	102.24	6.54	1.64	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	27.65	3.64	0.78	0.13	0.39	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	46.85	6.67	1.53	0.42	2.22	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	49.65	13.78	2.39	0.28	1.41	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	87.96	15.22	1.69	1.06	1.90	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	56.74	8.69	1.72	0.22	1.42	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	47.83	4.01	1.23	0.00	1.23	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	89.60	12.90	1.33	0.44	0.67	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	34.09	8.23	0.59	0.00	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	19.89	2.43	0.00	0.00	0.44	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	20.87	4.73	0.00	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	37.86	3.86	0.00	0.00	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	29.02	6.00	0.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	25.42	4.92	0.93	0.27	0.27	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	46.55	9.09	1.11	0.89	1.11	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	70.93	13.44	1.54	0.64	1.66	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	31.26	7.49	0.00	0.00	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	51.98	11.52	0.89	0.00	1.18	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	48.97	10.25	0.85	0.14	1.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.69	0.33	0.00	0.00	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	41.10	5.48	0.61	0.30	0.91	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	19.70	5.30	0.51	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	19.07	6.20	0.00	0.48	1.43	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	38.20	8.85	0.44	0.44	0.44	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	39.60	9.47	0.22	0.22	1.08	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	47.76	11.97	1.05	0.63	1.68	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	16.40	4.18	0.46	0.00	0.77	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	28.02	5.39	0.00	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	32.58	5.98	0.90	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.15	1.37	0.00	0.00	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	36.52	8.64	0.47	0.24	1.02	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	42.67	4.63	1.51	0.30	1.21	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	45.74	11.38	2.50	0.91	0.91	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	29.59	1.21	0.00	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	96.43	16.96	1.06	0.53	1.32	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	65.51	8.66	1.20	0.13	2.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	51.72	11.77	0.88	0.13	1.38	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	30.44	7.10	1.01	0.00	0.76	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	36.49	8.74	0.45	0.00	1.06	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.00	3.00	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	34.89	3.88	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	33.02	6.51	0.93	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	36.86	4.04	1.01	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	31.34	5.95	0.31	0.00	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.19	0.29	0.29	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	66.15	11.75	0.50	0.08	0.67	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	28.96	7.47	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	17.56	4.03	0.72	0.43	1.01	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	25.50	5.35	1.02	0.00	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	19.37	3.76	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	68.61	14.81	0.56	0.28	0.70	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	63.34	14.16	1.09	0.17	1.09	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	9.52	0.95	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	15.41	3.18	0.98	0.24	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	67.61	13.26	1.99	0.22	0.88	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	36.86	10.24	0.00	0.59	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	35.18	6.03	0.39	0.00	0.78	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	36.76	4.76	0.26	0.26	1.06	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	53.56	5.95	0.00	1.49	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	57.13	5.03	0.36	0.00	1.80	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	41.17	5.39	1.14	0.57	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	46.48	4.73	0.79	0.79	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	39.11	8.38	0.76	0.76	1.52	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	37.14	9.18	0.00	0.40	1.20	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	29.68	6.27	0.00	1.25	2.09	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	30.71	6.88	0.00	1.38	1.83	0.00
Synoviocyte, donor1	11291-117A4	32.32	6.40	1.18	0.84	1.68	0.17
Synoviocyte, donor2	11368-117I9	39.56	10.90	0.67	1.51	1.68	0.17
Synoviocyte, donor3	11440-118H9	31.50	4.24	0.89	0.67	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	15.72	2.50	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	13.66	2.78	0.23	0.00	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	21.94	3.94	0.50	0.00	0.72	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	12.76	2.32	0.00	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	12.60	4.58	0.00	2.29	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	53.27	9.23	0.74	0.86	2.21	0.00
Urethra, donor2	10319-105A4	62.94	7.19	0.00	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	9.03	0.27	0.00	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	10.82	0.40	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	7.79	0.92	0.00	0.00	0.46	0.00
Urothelial cells, donor0	11216-116B1	67.31	9.14	0.89	0.22	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	87.20	3.56	3.56	0.00	3.56	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	85.78	2.86	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	44.49	4.79	0.00	0.00	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	56.13	4.82	0.00	1.03	2.75	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	51.13	1.74	1.74	1.16	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	90.59	9.37	0.00	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	67.92	2.75	1.84	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	38.34	2.74	0.00	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	55.39	8.27	0.86	0.25	0.49	0.00
Wilms' tumor cell line:HFWT	10597-108E3	78.32	20.24	0.00	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	29.61	4.47	1.40	0.28	1.12	0.00
achilles tendon, donor2	10292-104G4	103.33	14.47	4.13	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	53.54	15.04	1.02	0.00	0.51	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	80.33	22.52	0.93	0.70	1.63	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	88.20	17.69	2.49	1.66	3.92	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	68.84	27.48	1.09	0.00	1.90	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	44.97	10.12	0.84	0.00	1.69	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	37.64	11.84	1.06	0.63	0.63	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	70.78	7.08	1.63	0.00	1.09	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	118.97	13.22	0.44	0.88	3.53	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	98.82	11.43	2.45	2.45	1.63	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	71.06	13.59	0.78	0.78	2.33	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	60.90	6.99	1.29	0.37	1.84	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	93.61	0.00	3.90	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	49.26	10.69	0.70	0.23	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	64.21	5.18	1.29	0.52	3.11	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	52.31	4.97	0.88	0.00	3.80	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	44.15	6.97	0.00	0.46	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	55.11	4.94	0.41	0.41	0.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	47.58	13.81	0.31	0.00	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	73.82	11.09	1.71	0.43	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	60.66	9.10	0.30	0.91	2.73	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	65.47	6.02	0.24	0.96	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	47.67	4.23	1.11	0.22	1.56	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	46.36	4.00	0.00	1.33	2.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	133.79	22.30	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	57.63	12.81	0.38	0.00	1.88	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	47.54	10.90	1.31	1.31	1.31	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	95.60	15.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	72.30	5.42	0.47	0.24	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	43.43	5.89	1.09	0.47	0.78	0.00
adipose, donor1	10184-103D4	100.86	33.43	0.00	0.00	1.76	0.00
adipose, donor2	10185-103D5	41.36	10.95	0.81	0.41	0.81	0.41
adipose, donor3	10186-103D6	47.65	12.53	1.09	0.00	1.91	0.00
adipose, donor4	10187-103D7	36.40	13.00	0.87	0.00	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	50.82	9.31	1.26	0.00	2.37	0.00
adrenal gland, adult, pool1	10081-102A9	50.93	7.28	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	72.71	6.14	2.00	2.27	1.60	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	63.96	6.79	1.43	0.71	1.43	0.00
amniotic membrane cells, donor1	12235-129G3	68.63	11.13	0.23	1.16	1.16	0.23
amniotic membrane cells, donor2	12236-129G4	41.59	13.86	1.01	0.68	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	86.02	10.90	0.29	0.29	1.47	0.00
amygdala - adult, donor10196	10167-103B5	64.03	8.30	3.56	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	55.56	9.73	1.01	0.20	1.42	0.00
amygdala, newborn, donor10223	10360-105E9	31.63	4.52	0.97	0.32	1.61	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	72.45	11.97	1.40	0.64	2.04	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	58.24	8.16	0.44	0.66	0.66	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	118.25	19.37	1.00	1.00	0.67	0.00
aorta, adult, pool1	10052-101G7	44.13	7.45	0.98	0.59	1.77	0.00
appendix, adult	10189-103D9	64.43	6.60	0.39	1.16	1.16	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	53.65	7.22	2.75	1.03	2.41	0.00
artery, adult	10190-103E1	40.76	10.87	1.36	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	29.70	9.27	0.87	0.14	1.01	0.00
b cell line:RPMI1788	10427-106D4	72.42	9.81	4.01	1.93	1.78	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	54.66	9.71	1.11	0.28	1.11	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	36.52	4.66	0.40	0.50	0.69	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	46.70	6.03	1.34	0.33	1.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	54.25	6.15	0.56	0.00	2.80	0.00
bladder, adult, pool1	10011-101C2	63.88	9.67	0.76	0.76	1.52	0.00
blood, adult, pool1	10053-101G8	57.58	8.86	2.21	2.21	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	57.38	7.71	1.71	0.86	0.00	0.00
bone marrow, adult	10192-103E3	43.19	4.72	0.00	0.00	0.67	0.00
brain, adult, donor1	10084-102B3	28.70	5.13	0.00	0.00	2.05	0.00
brain, adult, pool1	10012-101C3	41.09	6.46	0.89	0.22	1.34	0.00
brain, fetal, pool1	10085-102B4	24.04	8.01	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	148.00	26.76	0.99	0.33	1.65	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	48.68	8.11	1.00	1.50	2.12	0.00
breast, adult, donor1	10080-102A8	56.19	9.47	0.00	0.00	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	84.61	9.40	1.27	0.13	1.91	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	45.46	4.33	0.62	0.31	1.55	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	64.23	11.97	1.38	2.07	1.15	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	60.52	8.96	0.48	0.73	0.97	0.00
carcinoid cell line:NCI-H1770	10703-109H1	47.49	6.11	0.47	0.00	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	44.08	10.39	0.66	0.22	0.55	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	46.27	6.65	0.63	0.63	0.95	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	58.03	8.25	1.06	0.27	1.86	0.27
caudate nucleus - adult, donor10196	10177-103C6	66.78	9.21	0.00	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	53.88	8.53	0.00	0.17	2.01	0.17
caudate nucleus, adult, donor10258	10379-105H1	26.74	5.35	0.00	0.00	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	34.06	5.86	1.10	0.00	2.20	0.37
cerebellum - adult, donor10196	10173-103C2	104.88	5.83	2.91	0.00	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	94.80	7.90	0.85	0.00	5.98	0.00
cerebellum, adult, pool1	10083-102B2	42.43	5.52	0.69	0.34	1.72	0.00
cerebellum, newborn, donor10223	10357-105E6	65.59	5.81	0.00	0.83	4.15	0.00
cerebral meninges, adult	10188-103D8	49.17	8.07	0.25	0.76	1.01	0.25
cerebrospinal fluid, donor2	10294-104G6	57.01	5.12	0.73	0.73	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	85.84	12.37	0.58	0.29	0.58	0.00
cervical cancer cell line:ME-180	10553-107I4	42.42	12.26	1.16	0.50	0.50	0.00
cervix, adult, pool1	10013-101C4	56.80	12.28	0.52	0.31	2.20	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	45.29	9.20	0.98	1.25	1.39	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	48.33	11.76	0.00	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	61.52	9.94	0.62	0.37	2.61	0.00
choriocarcinoma cell line:SCH	10785-110H2	67.89	9.98	2.22	0.62	5.17	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	52.89	8.06	0.71	0.47	2.13	0.00
chorionic membrane cells, donor1	12238-129G6	45.59	12.25	1.42	2.28	1.42	0.00
chorionic membrane cells, donor2	12239-129G7	57.87	19.19	0.70	0.60	1.29	0.00
chorionic membrane cells, donor3	12240-129G8	65.94	12.64	2.75	0.55	1.65	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	44.43	6.06	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	97.78	12.68	1.15	0.38	1.34	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	74.97	11.19	0.21	0.42	2.11	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	88.85	4.11	1.28	0.51	3.08	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	76.19	4.11	1.21	0.73	2.90	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	97.94	8.76	1.02	0.61	1.22	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	83.04	10.31	1.18	1.18	1.18	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	52.39	20.59	0.00	0.00	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	41.37	5.49	2.29	0.46	0.46	0.00
clear cell carcinoma cell line:TEN	10636-108I6	55.35	6.42	2.43	0.52	2.26	0.35
colon carcinoma cell line:CACO-2	10513-107D9	78.71	27.46	2.75	2.20	3.11	0.55
colon carcinoma cell line:COLO-320	10420-106C6	84.38	17.10	1.14	0.76	1.52	0.00
colon, adult, donor1	10082-102B1	32.13	5.95	0.00	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	52.41	5.52	0.24	0.82	1.29	0.12
colon, fetal, donor1	10070-101I7	65.51	11.12	0.00	0.00	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	183.34	32.08	0.00	4.58	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	125.78	16.57	5.10	5.52	0.00	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	80.60	14.34	0.75	1.81	0.15	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	87.29	17.49	1.27	2.68	0.14	0.14
corpus callosum, adult, pool1	10042-101F6	40.24	7.85	0.77	0.22	1.11	0.00
cruciate ligament, donor2	10295-104G7	84.29	14.59	2.43	0.81	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	73.03	20.87	0.00	0.00	2.41	0.00
diencephalon, adult	10193-103E4	46.80	6.48	0.72	0.00	0.96	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	56.71	9.18	1.38	0.23	0.69	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	58.21	3.59	0.77	0.51	2.31	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	54.64	13.24	1.69	0.24	2.89	0.00
ductus deferens, adult	10196-103E7	58.31	9.97	1.00	0.00	2.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	63.37	10.08	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	62.53	11.77	0.74	0.74	1.47	0.00
dura mater, adult, donor1	10041-101F5	75.40	8.18	3.06	0.91	1.16	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	32.20	8.44	12.66	4.00	1.55	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	34.53	7.31	0.43	0.57	2.87	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	53.03	4.93	3.08	0.62	2.47	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	59.03	4.84	3.03	0.91	3.63	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	49.71	8.03	2.47	0.31	2.78	0.00
embryonic pancreas cell line:2C6	10603-108E9	77.49	6.57	2.63	2.63	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	40.56	15.08	1.34	0.34	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	58.54	16.13	1.45	0.54	2.72	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	39.40	6.59	0.96	0.64	1.29	0.00
epidermoid carcinoma cell line:A431	10426-106D3	51.80	8.67	1.67	0.89	1.11	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	68.85	7.81	1.54	0.44	1.43	0.00
epididymis, adult	10197-103E8	73.89	8.37	0.63	1.26	1.88	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	28.92	4.61	0.35	0.18	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	30.67	7.47	0.39	0.00	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	46.13	10.48	0.92	0.39	2.49	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	56.49	8.66	1.08	0.69	1.97	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	51.53	7.95	1.01	0.22	1.79	0.22
esophagus, adult, pool1	10015-101C6	56.27	8.71	0.53	0.42	1.70	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	71.26	14.03	1.50	1.75	1.25	0.25
eye - muscle inferior rectus, donor1	10272-104E2	137.63	14.49	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	109.42	12.63	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	145.85	13.39	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	97.45	10.32	1.15	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	59.75	7.29	1.46	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	61.52	11.95	0.25	0.51	0.76	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	65.91	10.13	2.31	0.64	1.15	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	90.22	12.35	2.37	0.95	4.99	0.24
frontal lobe, adult, pool1	10040-101F4	47.76	6.94	0.28	0.09	1.97	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	58.25	11.11	0.90	0.60	0.30	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	63.46	6.03	0.37	0.37	1.01	0.09
gall bladder, adult	10198-103E9	44.18	7.73	0.48	1.21	1.69	0.00
gamma delta positive T cells, donor1	11937-126A2	97.71	8.59	2.15	2.68	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	98.60	11.95	2.24	1.12	1.49	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	41.82	10.98	0.00	0.63	0.84	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	74.66	9.09	0.00	0.39	0.77	0.00
gastric cancer cell line:AZ521	10549-107H9	58.20	15.08	0.98	0.66	3.12	0.00
gastric cancer cell line:GSS	10560-108A2	25.63	1.83	0.92	0.92	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	47.29	11.65	2.97	0.23	1.60	0.00
giant cell carcinoma cell line:LU65	10487-107B1	52.90	4.25	2.41	0.80	1.72	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	93.63	7.42	1.26	0.56	1.12	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	62.35	8.23	1.50	0.25	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	52.99	8.34	1.16	0.74	1.48	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	50.84	12.92	1.97	0.28	2.11	0.28
glioblastoma cell line:T98G	10485-107A8	43.49	5.96	0.66	0.99	0.55	0.00
glioma cell line:GI-1	10413-106B8	52.43	11.42	1.46	0.00	1.17	0.00
globus pallidus - adult, donor10196	10175-103C4	56.13	6.56	0.73	0.00	2.19	0.00
globus pallidus, adult, donor10252	10161-103A8	65.17	12.45	0.24	0.24	2.20	0.00
globus pallidus, adult, donor10258	10367-105F7	42.45	2.74	1.37	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	30.91	7.46	0.53	1.07	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	259.40	53.84	2.45	2.45	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	53.12	9.60	0.64	0.00	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	54.18	5.05	0.00	0.00	1.84	0.00
hIPS +CCl2, biol_rep2	14384-156C1	48.01	2.74	0.00	0.00	1.37	0.00
hIPS +CCl2, biol_rep3	14385-156C2	66.99	5.80	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	84.80	5.75	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	48.01	5.49	0.00	0.00	1.37	0.00
hIPS, biol_rep3	14382-156B8	56.28	3.31	0.00	0.00	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	64.08	9.48	0.57	1.15	1.15	0.00
heart - mitral valve, adult	10205-103F7	51.42	8.67	1.49	1.20	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	50.46	4.97	0.78	0.26	2.09	0.00
heart - tricuspid valve, adult	10207-103F9	56.62	9.16	0.00	1.67	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	36.93	5.92	0.20	0.82	0.82	0.00
heart, adult, diseased, donor1	10051-101G6	43.43	2.13	0.85	0.00	0.85	0.00
heart, adult, pool1	10016-101C7	61.63	9.89	0.23	0.00	1.15	0.00
heart, fetal, pool1	10046-101G1	60.89	11.91	1.44	0.72	0.82	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	62.32	12.03	0.31	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	66.59	15.46	4.76	1.19	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	52.82	18.89	0.77	0.77	1.99	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	48.79	20.51	1.21	1.34	1.34	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	52.24	16.37	1.31	1.31	2.32	0.00
hepatoma cell line:Li-7	10484-107A7	69.84	12.46	1.00	0.78	1.33	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	58.89	11.56	0.90	0.30	1.41	0.10
hippocampus - adult, donor10196	10169-103B7	70.03	5.68	0.95	0.00	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	62.25	6.33	0.82	0.00	2.86	0.20
hippocampus, adult, donor10258	10374-105G5	61.75	2.99	0.00	0.00	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	29.61	5.29	0.00	0.70	1.06	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	54.93	18.31	0.61	0.61	2.44	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	35.15	13.35	0.79	0.00	1.57	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	41.13	11.68	1.52	0.25	2.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	42.85	6.77	0.00	0.00	1.69	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	35.37	13.69	0.52	0.00	1.03	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	31.51	5.31	0.00	0.00	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	47.59	5.55	0.29	0.00	2.63	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	53.86	11.63	1.08	0.65	2.80	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	39.20	10.43	1.25	0.42	1.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	47.60	12.31	0.95	0.71	3.32	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	42.11	15.27	1.29	0.96	2.89	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	53.86	12.12	0.67	0.00	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	35.68	14.24	0.78	0.16	3.44	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	42.25	10.81	1.47	0.49	2.95	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	44.51	12.22	0.87	0.00	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	47.54	11.84	0.19	0.00	0.57	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	46.66	8.29	0.00	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	45.48	14.99	0.00	0.50	2.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	42.58	8.29	0.75	0.00	2.26	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	45.47	13.19	0.91	0.45	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	46.99	8.14	0.31	0.00	1.88	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	33.80	12.57	1.63	0.33	1.96	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	35.42	15.68	0.87	0.00	0.58	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	36.77	11.66	0.60	0.60	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	38.80	12.93	1.66	0.55	2.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	40.51	11.70	1.71	0.86	1.43	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	47.77	21.64	1.22	0.00	2.45	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	43.66	10.21	0.35	0.00	1.06	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	38.96	9.50	0.00	0.00	1.58	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	33.59	9.99	0.30	0.00	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	48.61	13.96	1.03	1.03	2.59	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	49.81	16.60	0.66	1.99	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	40.02	9.24	0.77	0.77	2.05	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	43.46	12.27	1.28	1.53	2.81	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	46.19	16.66	2.27	1.51	3.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	40.66	13.11	0.67	0.67	1.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	44.92	10.87	0.24	0.48	1.93	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	40.55	11.14	0.89	1.34	2.23	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	36.10	12.68	0.49	0.49	1.95	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	47.07	12.84	0.00	0.31	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	169.17	45.55	3.25	3.25	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	50.30	12.24	0.33	0.00	0.99	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	48.16	6.57	0.55	1.09	2.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	53.20	6.51	0.36	0.72	3.62	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	42.70	6.05	0.36	0.00	3.56	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	40.58	4.77	3.58	1.19	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	65.14	16.66	0.54	0.41	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	35.29	8.62	1.62	0.27	0.81	0.00
immature langerhans cells, donor1	11904-125F5	62.23	12.35	3.15	4.60	0.00	0.97
immature langerhans cells, donor2	11905-125F6	64.95	10.30	16.63	15.05	0.79	1.58
insula, adult, pool1	10039-101F3	39.94	6.34	0.28	0.00	1.23	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	43.57	9.75	1.30	0.65	2.93	0.00
kidney, adult, pool1	10017-101C8	45.26	8.81	0.70	0.30	1.90	0.00
kidney, fetal, pool1	10045-101F9	28.15	4.88	0.42	0.14	2.12	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	55.67	16.76	0.43	0.71	0.71	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	35.11	8.16	0.55	0.41	1.11	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	89.73	5.87	0.55	0.00	0.55	0.00
left atrium, adult, donor1	10079-102A7	58.30	8.72	0.54	0.00	2.72	0.00
left ventricle, adult, donor1	10078-102A6	62.20	9.61	0.51	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	70.59	9.30	1.37	0.55	1.09	0.00
leiomyoma cell line:10964C	10569-108B2	17.96	1.80	1.08	0.00	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	28.80	2.72	0.54	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	33.51	4.61	0.97	0.49	0.97	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	12.70	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	75.28	5.23	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	116.05	22.43	1.89	1.30	1.77	0.00
liposarcoma cell line:KMLS-1	10782-110G8	67.48	11.72	1.25	0.00	1.25	0.00
liposarcoma cell line:SW 872	10726-110A6	37.65	6.21	0.37	0.12	0.12	0.00
liver, adult, pool1	10018-101C9	61.91	14.91	0.81	0.16	1.94	0.00
liver, fetal, pool1	10086-102B5	31.04	13.17	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	36.75	6.42	1.02	0.58	0.44	0.15
locus coeruleus, adult, donor10252	10165-103B3	46.88	7.94	1.11	0.37	2.95	0.00
locus coeruleus, adult, donor10258	10375-105G6	26.52	8.18	0.56	0.00	1.41	0.00
locus coeruleus, newborn, donor10223	10362-105F2	48.79	5.05	0.42	0.42	3.36	0.00
lung adenocarcinoma cell line:A549	10499-107C4	48.99	10.38	0.42	0.14	0.97	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	41.36	6.20	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	43.10	8.96	0.79	0.26	0.40	0.00
lung, adult, pool1	10019-101D1	50.91	9.69	1.77	0.95	0.71	0.00
lung, fetal, donor1	10068-101I5	97.04	13.70	0.57	0.29	1.14	0.00
lung, right lower lobe, adult, donor1	10075-102A3	53.61	14.20	0.46	0.92	0.92	0.00
lymph node, adult, donor1	10077-102A5	56.80	10.41	0.00	0.00	1.42	0.00
lymphangiectasia cell line:DS-1	10727-110A7	65.53	8.99	1.53	0.88	1.10	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	62.63	13.13	1.96	0.91	2.26	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	66.26	9.34	2.55	2.55	2.55	0.00
mature adipocyte, donor1	12231-129F8	60.83	11.99	3.11	3.55	0.89	0.44
mature adipocyte, donor2	12232-129F9	56.86	10.17	4.77	3.11	0.42	0.21
mature adipocyte, donor3	12233-129G1	49.78	7.11	4.03	3.08	2.61	0.47
mature adipocyte, donor4	12234-129G2	52.38	8.16	5.00	5.53	0.79	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	57.90	6.91	0.24	0.00	1.19	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	47.38	5.64	1.13	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	62.71	10.30	0.37	0.18	2.94	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	50.19	2.54	0.64	0.00	0.64	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	43.50	11.52	0.43	1.71	1.28	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	46.58	11.31	0.17	1.18	2.36	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	67.70	8.91	0.64	0.42	1.91	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	109.80	0.00	1.93	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	33.74	3.59	0.36	1.79	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	64.90	6.49	1.30	0.00	1.95	0.00
medulla oblongata, adult, donor10252	10155-103A2	57.43	7.89	1.08	0.31	2.63	0.00
medulla oblongata, adult, pool1	10038-101F2	31.34	5.80	0.57	0.16	1.47	0.00
medulla oblongata, newborn, donor10223	10361-105F1	31.25	3.82	0.35	1.04	1.39	0.00
medulloblastoma cell line:D283 Med	10838-111E1	109.38	23.25	3.32	1.11	3.10	0.00
medulloblastoma cell line:ONS-76	10759-110E3	40.72	8.07	0.61	0.24	1.22	0.00
melanoma cell line:COLO 679	10514-107E1	24.58	6.32	0.29	0.43	0.14	0.14
melanoma cell line:G-361	10465-106H6	32.85	4.34	0.54	0.27	0.81	0.27
meningioma cell line:HKBMM	10691-109F7	44.68	4.52	0.72	0.36	1.09	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	88.12	15.86	2.64	1.76	5.29	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	37.59	9.33	0.52	0.00	1.30	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	53.24	15.65	0.77	0.31	0.77	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	41.08	16.54	1.09	0.18	0.36	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	45.55	6.21	1.24	0.00	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	35.12	9.27	0.84	0.14	0.42	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	30.43	11.94	1.16	0.39	1.16	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	31.23	2.78	0.00	0.00	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	44.45	14.93	1.37	0.51	0.34	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	36.69	10.24	1.27	0.46	0.46	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	40.98	11.67	1.06	0.53	0.53	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	53.75	14.58	1.76	0.68	0.81	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	47.94	17.36	1.00	0.14	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	34.91	8.56	1.32	0.33	0.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	52.72	17.02	1.11	0.28	0.97	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	48.52	9.77	1.05	1.40	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	52.06	12.45	1.22	0.61	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	31.63	7.55	1.08	0.36	1.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	42.72	8.59	1.14	0.52	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	26.45	6.61	0.91	0.46	1.82	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	72.16	20.56	0.42	0.42	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	39.90	13.60	1.49	0.45	0.90	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	48.14	14.27	2.19	1.05	1.40	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	33.87	5.89	1.10	0.00	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	33.48	8.58	0.86	1.14	1.14	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	48.84	8.84	0.00	0.84	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	40.19	11.42	0.91	0.46	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	38.11	8.70	0.77	0.51	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	43.45	8.64	0.26	0.00	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	36.05	7.39	0.62	0.00	0.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	37.89	7.77	0.47	0.47	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	36.89	7.11	0.00	0.34	1.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	36.55	7.47	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	31.51	7.88	0.93	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	46.44	10.09	0.29	0.29	2.31	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	42.39	8.48	0.45	0.22	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	40.38	6.73	0.48	0.00	1.20	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	49.13	8.07	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	32.22	5.71	0.34	0.34	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	31.93	7.37	0.41	0.00	1.23	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	34.36	5.58	0.43	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	51.95	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00	5.16	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	30.21	9.09	0.65	0.00	1.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	27.64	7.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	29.85	7.46	0.00	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	33.53	9.00	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	35.37	11.27	0.00	0.39	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	42.72	4.97	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	38.14	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	38.54	8.30	0.00	0.00	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	34.12	7.31	1.22	0.00	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	31.04	6.97	0.63	0.63	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	30.35	7.93	1.03	0.00	1.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	23.64	8.60	0.00	0.00	6.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	7.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	13.78	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	20.37	4.89	0.81	0.41	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.83	7.15	1.59	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.63	6.48	1.18	1.77	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	32.73	7.17	0.62	0.00	1.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	28.07	5.35	2.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	30.75	11.83	0.00	0.00	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	25.68	7.70	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	32.35	7.57	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	39.58	11.38	0.49	0.00	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	38.13	5.61	1.12	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	44.52	5.72	0.00	1.27	2.54	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	28.61	5.24	0.40	0.40	1.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	10.90	0.00	0.00	6.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	16.47	2.53	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	52.19	6.68	1.82	1.82	2.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	63.27	18.08	4.52	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	56.83	14.00	0.82	0.00	2.47	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	44.25	5.95	0.40	0.60	0.99	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	30.50	8.11	0.65	0.00	1.62	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	22.41	8.15	0.00	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	46.42	10.83	1.55	0.77	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	93.32	6.85	2.36	0.47	3.54	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	33.59	8.11	2.78	1.39	0.93	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	55.56	12.82	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	53.33	12.95	1.23	0.62	0.82	0.10
mesothelioma cell line:Mero-25	10850-111F4	40.40	3.63	1.82	0.68	1.82	0.00
mesothelioma cell line:Mero-41	10851-111F5	68.45	4.16	0.73	0.24	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	14.39	2.21	0.44	0.00	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	57.03	9.99	1.31	1.58	2.63	0.00
mesothelioma cell line:Mero-83	10854-111F8	39.66	4.94	0.68	0.17	0.34	0.00
mesothelioma cell line:Mero-84	10855-111F9	30.84	4.30	0.51	0.76	0.76	0.00
mesothelioma cell line:Mero-95	10856-111G1	30.23	8.70	0.62	0.41	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	27.50	4.64	0.33	0.33	1.49	0.00
mesothelioma cell line:NCI-H226	10846-111E9	44.89	8.69	1.45	0.72	1.81	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	92.41	8.88	5.12	1.71	7.52	0.17
mesothelioma cell line:NCI-H28	10845-111E8	55.73	8.40	1.27	0.76	1.53	0.00
mesothelioma cell line:No36	10857-111G2	39.80	2.28	2.28	0.33	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	57.17	4.88	1.90	1.35	1.63	0.27
migratory langerhans cells, donor1	11901-125F2	60.65	7.48	0.77	1.34	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	49.21	4.03	1.22	0.49	0.37	0.00
migratory langerhans cells, donor3	11903-125F4	53.84	6.46	1.26	1.26	0.90	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	51.91	6.20	0.65	1.31	1.96	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	57.86	23.10	1.48	0.64	1.91	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	132.46	17.97	0.23	0.23	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	53.47	6.85	0.57	1.90	0.00	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	109.03	21.07	1.11	0.92	3.88	0.00
myeloma cell line:PCM6	10474-106I6	36.96	10.08	1.19	0.79	1.19	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	51.74	14.71	0.51	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	54.33	5.10	1.37	0.98	0.98	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	65.18	6.46	1.00	0.11	2.67	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	50.38	6.91	0.74	0.00	1.69	0.00
nasal epithelial cells, donor2	12227-129F4	76.73	8.83	0.55	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	61.89	16.56	1.15	0.69	3.22	0.00
neuroblastoma cell line:NB-1	10539-107G8	81.38	15.15	0.19	0.94	2.25	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	66.22	10.76	0.21	0.00	2.32	0.00
neuroblastoma cell line:NH-12	10555-107I6	83.67	10.06	1.30	0.75	2.80	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	33.69	9.49	2.14	0.24	1.19	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	45.30	10.61	0.32	0.16	1.11	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	43.47	7.04	0.20	0.00	1.61	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	55.95	5.09	0.00	0.64	1.91	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	56.43	7.72	0.53	0.27	1.06	0.00
neutrophil PMN, donor1	12133-128D9	208.25	29.75	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	26.56	13.28	13.28	0.00
neutrophil PMN, donor3	12141-128E8	37.88	9.47	18.94	18.94	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	155.76	35.01	1.69	2.37	3.72	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	47.23	8.01	0.80	0.80	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	49.69	8.98	1.60	2.24	1.28	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	45.20	9.99	1.31	1.05	1.58	0.00
nucleus accumbens, adult, pool1	10037-101F1	40.96	5.72	0.28	0.37	0.84	0.00
occipital cortex - adult, donor10196	10172-103C1	74.17	12.36	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	64.94	11.27	0.54	0.27	2.68	0.00
occipital cortex, newborn, donor10223	10355-105E4	24.75	4.37	1.09	0.36	1.82	0.00
occipital lobe, adult, donor1	10076-102A4	53.00	12.86	0.00	0.26	0.52	0.00
occipital lobe, fetal, donor1	10073-102A1	86.68	23.17	0.43	0.00	0.86	0.00
occipital pole, adult, pool1	10036-101E9	20.10	2.84	0.47	0.16	0.32	0.00
olfactory region, adult	10195-103E6	51.20	7.07	0.57	0.19	0.57	0.00
optic nerve, donor1	10277-104E7	94.05	6.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	56.27	10.02	2.05	0.34	6.26	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	79.27	8.11	1.92	1.65	1.10	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	43.69	9.99	0.17	0.34	0.51	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	43.66	10.28	0.92	0.12	0.69	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	44.39	6.17	0.59	0.29	0.88	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	84.09	14.95	0.93	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	71.46	15.48	1.06	0.21	1.27	0.21
ovary, adult, pool1	10020-101D2	60.53	8.82	0.17	0.17	1.40	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	50.78	9.53	0.92	0.55	0.18	0.00
pancreas, adult, donor1	10049-101G4	57.38	11.29	0.00	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	29.91	3.91	0.28	0.00	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	41.57	3.07	0.34	1.02	1.36	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	55.14	11.09	2.81	0.99	0.50	0.33
paracentral gyrus, adult, pool1	10035-101E8	42.47	6.32	0.73	0.18	1.37	0.00
parietal cortex, adult, donor10258	10373-105G4	46.98	0.73	1.47	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	60.19	8.46	1.88	0.00	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	57.58	9.12	0.57	0.00	3.14	0.00
parietal lobe, adult, pool1	10034-101E7	37.72	5.20	0.62	0.09	1.15	0.09
parietal lobe, fetal, donor1	10072-101I9	112.50	17.46	0.97	0.00	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	37.39	5.61	1.50	0.37	1.12	0.00
parotid gland, adult	10199-103F1	46.25	6.17	0.62	0.00	3.08	0.00
penis, adult	10200-103F2	49.41	7.52	2.69	0.00	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	100.78	5.58	0.93	0.56	2.42	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	39.92	5.97	0.87	0.29	0.87	0.00
pineal gland - adult, donor10196	10179-103C8	93.53	16.13	0.65	0.65	3.23	0.00
pineal gland, adult, donor10252	10160-103A7	96.53	22.50	0.00	0.00	2.96	0.00
pineal gland, adult, donor10258	10377-105G8	48.28	6.90	0.63	0.00	6.27	0.00
pituitary gland - adult, donor10196	10180-103C9	101.18	15.18	0.00	0.00	6.07	0.00
pituitary gland, adult, donor10252	10162-103A9	106.32	17.72	1.04	0.00	5.73	0.00
pituitary gland, adult, donor10258	10378-105G9	59.59	8.51	0.00	0.85	1.70	0.00
placenta, adult, pool1	10021-101D3	56.12	9.57	0.54	0.97	3.01	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	80.38	13.90	6.62	2.12	1.59	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	76.26	13.85	0.16	0.47	0.31	0.16
pons, adult, pool1	10033-101E6	41.14	6.37	0.69	0.26	2.41	0.00
postcentral gyrus, adult, pool1	10032-101E5	27.46	4.71	0.52	0.09	0.87	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	186.13	50.19	8.37	8.37	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	5.51	11.02	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	11.74	0.00	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	48.94	6.99	1.46	0.44	1.02	0.00
prostate cancer cell line:PC-3	10439-106E7	47.92	11.25	0.54	0.73	0.91	0.00
prostate, adult, pool1	10022-101D4	51.51	6.71	0.82	0.09	1.18	0.00
putamen, adult, donor10196	10176-103C5	66.10	9.21	0.47	0.24	1.18	0.00
putamen, adult, donor10252	10152-102I8	60.78	9.80	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	87.42	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	43.01	4.83	0.24	0.24	0.72	0.00
putamen, newborn, donor10223	10365-105F5	55.47	6.75	0.75	0.00	2.25	0.75
rectal cancer cell line:TT1TKB	10469-106I1	98.92	15.13	1.45	2.33	2.62	0.00
rectum, fetal, donor1	10067-101I4	109.89	30.60	1.39	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	51.52	6.36	1.48	0.21	1.48	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	102.31	6.21	2.07	0.83	0.83	0.00
retina, adult, pool1	10030-101E3	56.16	6.86	0.80	0.70	3.18	0.00
retinoblastoma cell line:Y79	10475-106I7	84.70	14.81	0.78	0.78	4.16	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	51.39	11.80	0.37	0.25	1.23	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	28.12	6.75	0.00	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	58.35	12.88	0.76	0.00	1.52	0.00
salivary acinar cells, donor1	11771-123I7	33.83	10.20	1.29	0.49	0.97	0.16
salivary acinar cells, donor2	11772-123I8	28.23	9.36	1.24	0.55	0.69	0.00
salivary acinar cells, donor3	11773-123I9	37.74	12.58	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	44.61	4.00	0.00	0.57	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	47.21	5.56	1.26	0.25	2.61	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	51.72	6.11	0.82	0.71	1.76	0.00
seminal vesicle, adult	10201-103F3	62.96	10.05	0.53	0.00	1.59	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	28.42	4.62	0.73	1.94	0.73	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	29.44	3.02	1.01	1.01	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	48.17	4.01	3.01	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	38.01	6.45	0.54	1.07	1.34	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	60.90	4.75	1.66	0.66	1.44	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	39.61	5.42	0.39	0.90	0.26	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	156.05	16.31	0.00	0.00	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	66.57	8.88	0.72	0.12	0.96	0.00
skeletal muscle, fetal, donor1	10066-101I3	41.21	16.08	0.00	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	47.50	13.57	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	89.00	22.72	1.26	0.63	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	75.04	9.34	1.67	0.67	5.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	43.81	13.24	0.63	0.32	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	91.94	15.81	3.47	0.39	2.70	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	60.66	8.08	0.66	0.33	2.47	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	86.22	4.34	0.80	0.80	0.97	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	42.71	12.42	0.87	0.65	0.65	0.22
small intestine, adult, pool1	10024-101D6	60.68	7.76	0.84	0.24	2.39	0.00
small intestine, fetal, donor1	10064-101I1	49.88	12.04	0.74	0.00	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	33.85	3.59	0.51	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	58.93	7.24	0.78	0.26	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	68.61	7.24	0.27	0.00	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	52.76	10.09	0.69	0.46	0.92	0.00
spinal cord, adult, donor10252	10159-103A6	52.04	7.49	0.00	0.39	1.97	0.00
spinal cord, adult, donor10258	10369-105F9	69.87	5.53	0.00	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	62.20	14.64	0.00	1.22	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	61.08	10.10	0.00	0.92	1.38	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	59.29	6.57	0.15	0.30	0.60	0.00
spleen, adult, pool1	10025-101D7	45.93	9.25	1.10	0.22	1.21	0.00
spleen, fetal, pool1	10044-101F8	28.05	6.20	0.79	0.40	0.64	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	42.85	6.62	1.35	0.93	1.14	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	33.42	7.78	1.14	0.19	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	31.10	8.74	1.05	1.40	1.05	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	50.82	9.38	0.39	0.39	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	50.54	8.89	2.14	0.34	2.48	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	65.23	5.93	0.42	0.42	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	40.19	4.65	0.00	0.85	1.69	0.00
stomach, fetal, donor1	10062-101H8	76.89	13.88	1.07	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	58.11	6.84	0.57	0.57	2.85	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	45.07	7.27	1.45	0.21	0.83	0.00
substantia nigra, adult, donor10258	10371-105G2	50.17	1.55	0.00	0.00	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	28.97	3.53	0.71	1.41	2.12	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	75.43	22.70	0.23	0.00	2.06	0.00
temporal lobe, adult, pool1	10031-101E4	20.77	4.07	0.42	0.17	0.59	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	75.50	24.93	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	49.23	6.15	0.44	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	58.30	12.92	1.05	0.35	2.09	0.00
tenocyte, donor2	11765-123I1	42.73	8.01	1.53	0.38	1.14	0.00
tenocyte, donor3	11768-123I4	47.82	5.19	0.37	0.37	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	84.13	11.90	0.17	0.68	1.70	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	59.96	22.51	1.08	1.39	1.23	0.15
teratocarcinoma cell line:PA-1	10807-111A6	67.88	12.09	0.15	0.00	0.46	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	57.51	9.39	0.13	0.89	1.14	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	68.45	11.35	0.00	0.00	1.89	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	99.46	24.87	0.65	0.00	1.85	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	36.15	1.63	0.00	0.65	1.63	0.00
testis, adult, pool1	10026-101D8	75.91	12.24	0.97	0.54	2.47	0.00
testis, adult, pool2	10096-102C6	73.08	3.16	0.45	0.45	5.41	0.00
thalamus - adult, donor10196	10168-103B6	62.93	9.94	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	53.29	7.03	1.25	0.16	1.41	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	146.26	1.54	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	29.81	5.27	0.33	0.16	0.66	0.00
thalamus, newborn, donor10223	10366-105F6	46.03	9.21	1.73	1.73	3.45	0.58
throat, adult	10209-103G2	58.17	6.99	0.75	0.00	0.75	0.25
throat, fetal, donor1	10061-101H7	78.31	21.94	0.30	0.30	1.22	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	59.42	19.08	0.40	0.60	6.16	0.00
thymus, adult, pool1	10027-101D9	84.70	12.92	1.29	0.40	1.89	0.10
thymus, fetal, pool1	10043-101F7	79.07	12.68	2.60	1.25	4.36	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	53.18	10.37	1.60	0.66	1.33	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	94.71	9.36	1.12	0.42	1.54	0.00
thyroid, adult, pool1	10028-101E1	63.92	11.20	0.93	0.28	2.52	0.00
thyroid, fetal, donor1	10060-101H6	68.03	18.72	0.00	0.00	1.05	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	92.39	9.24	3.08	0.00	3.08	0.00
tongue, adult	10203-103F5	53.73	7.91	1.16	0.47	0.47	0.00
tongue, fetal, donor1	10059-101H5	87.09	18.13	0.79	0.00	2.36	0.00
tonsil, adult, pool1	10047-101G2	51.19	5.91	0.90	0.50	1.60	0.00
trachea, adult, pool1	10029-101E2	50.96	8.26	0.82	0.16	0.98	0.00
trachea, fetal, donor1	10058-101H4	80.79	19.23	0.77	1.15	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	58.81	8.86	0.35	0.35	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	39.11	9.63	0.91	0.81	1.62	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	81.48	10.50	2.98	0.78	1.10	0.00
tridermal teratoma cell line:HGRT	10694-109G1	78.00	22.83	0.00	0.00	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	55.78	7.62	0.59	0.34	0.85	0.00
umbilical cord, fetal, donor1	10057-101H3	37.56	10.43	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	61.60	6.65	1.37	0.17	1.54	0.00
uterus, fetal, donor1	10055-101H1	90.10	19.45	1.02	0.00	1.54	0.00
vagina, adult	10204-103F6	50.40	5.17	0.00	0.00	1.94	0.00
vein, adult	10191-103E2	42.31	7.23	0.66	0.00	0.66	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	39.25	5.07	2.94	1.34	0.27	0.27